ME/CFS South Australia Inc: Symptoms Of Chronic Fatigue Syndrome Linked With Non-Celiac Wheat Sensitivity

ME/CFS SOUTH AUSTRALIA INC

Registered Charity 3104

Email:
sacfs@sacfs.asn.au

Mailing address:
PO Box 322,
Modbury North,
South Australia 5092

Phone:
1300 128 339

Office Hours:
Monday - Friday,
10am - 4pm
(phone)

ME/CFS South Australia Inc supports the needs of sufferers of Myalgic Encephalomyelitis, Chronic Fatigue Syndrome and related illnesses. We do this by providing services and information to members.

ME/CFS South Australia Inc aims to keep members informed of various research projects, diets, medications, therapies, news items, etc. All communication, both verbal and written, is merely to disseminate information and not to make recommendations or directives.

Unless otherwise stated, the views expressed on this Web site are not necessarily the official views of the Society or its Committee and are not simply an endorsement of products or services.

Symptoms Of Chronic Fatigue Syndrome Linked With Non-Celiac Wheat Sensitivity

Friday 22 June 2018

Principal Investigator
Armin Alaedini, PhD,
Columbia University Medical Center.

Symptoms of Chronic Fatigue Syndrome Linked with Non-Celiac Wheat Sensitivity

In a new study, researchers from Columbia University Medical Center have found that a significant subset of patients with chronic fatigue syndrome has gastrointestinal symptoms and blood markers associated with non-celiac wheat sensitivity (NCWS).

Extreme fatigue that does not improve with rest is the defining symptom of myalgic encephalomyelitis (ME), commonly known as chronic fatigue syndrome (CFS). However, many CFS sufferers also report intestinal symptoms and show immune system issues upon testing. The Columbia University researchers were curious to see whether some patients with CFS may have certain blood markers associated with NCWS, which might explain some of their corresponding symptoms.

Blood samples from 131 known CFS patients and 86 healthy controls were screened for the same markers identified in a previous study on NCWS. All study participants were also given a questionnaire to rate gastrointestinal symptom severity. Using these tools, 20 of the CFS patients were identified as having blood markers of NCWS, while only 4 control subjects had these markers, a significant difference between the two groups. There was also a strong relationship between the possibility of NCWS and high severity score on the gastrointestinal symptom questionnaire.